|
A SPECIAL
ANNOUNCEMENT FROM: |
|
 |
|
|
|
|
|
|
Industry Experts Share the Latest on Accelerated Development and Better Treatments by Design
|
|
|
|
|
|
Catalent
experts will present on a breadth of industry topics at the AAPS,
featuring more than 25 research posters, seminars, workshops and
roundtables. Here is a sample of topics from our AAPS program:
-
A Dose of Innovation: Strategies to incorporate patient focused design into the formulation space
- Better Treatments by Design: An overview of patient focused dose form design
- Cornell
Stamoran, VP Corporate Strategy, Catalent
- Avoiding The Landmines: The biggest challenges in the drug development- considerations, and best practices
- Edward Narke, Principal, DS InPharmatics (DSI)
- Start Earlier, Move Faster: Smart
Drug Development & Design from Candidate to Phase I
- Julien Meissonnier, VP, Science & Technology, Catalent
- Phase In, phase \Out: Strategies for progressing to phase I formulations to improve your speed to and success in clinic
- Brent
Moody, Principal Scientist, Catalent
- Formulation Approaches to Enhance Bioavailability of Oral Anticancer Drugs
- Julien Meissonnier, VP, Science & Technology, Catalent
Join
us after the sessions at our booth, #3016, to network, enjoy
refreshments, and dive deeper into the topics with the speakers,
Catalent experts and your industry colleagues.
Click here
for details and to RSVP for these informative sessions. If you can’t join us, contact us to request presentation copies.
|
|
|
|
|
|
|
Come discuss your projects with Catalent at AAPS
|
|
|
|
|
|
|
|
Catalent
has the passion to unlock the potential of your small and large
molecules with deepest experience and widest array of solutions to meet
your development challenges. With EXPANDED
early development solutions, NEW Dose Form offering for
better outcomes, and EXPANDED biologics and sterile fill finish capabilities via our acquisition
of Cook Pharmica, Catalent has you covered with a full range of services from preclinical to commercial launch.
|
|
---|
|
|
|
|
|
|
|
|
Award Winning Optiform® Solution Suite Expanded to Include Early Development
|
|
|
|
|
|
|
Catalent has expanded OptiForm® Solution Suite
to include early development to let you start fast and start smart to guide your molecule’s progress to clinic, including:
- Candidate selection: Solubility testing, DMPK modeling, pre-formulation testing
- API Optimization: polymorph screening, salt-form selection
- Bioavailability enhancement:
Micronization, co-micronization lipid systems, and amorphous dispersions including spray dry and hot melt extrusion
- GLP test materials: toxicology and pk/pd analysis
- GMP clinical materials: Phase I studies and beyond
|
|
---|
|
|
|
|
|
Can't Wait? Latest News, Articles and Webinars
|
|
|
|
|
Oral Drug Delivery
Biologics
Clinical Supply Services
Consumer Health
|
|
|
|
|
|
|
Every molecule has a challenge. We have a solution.
|
|
|
|
|
or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
|
|
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected],
or visit our website www.catalent.com.
And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.
Catalent Pharma Solutions respects your privacy.
Links to third party sites are provided as a
convenience only. Catalent makes no representation or warranty about the
technology, security or any content available at these sites. Links are
not intended to imply Catalent's affiliation or endorsement or the
website, its owner(s) or the content.
|
© 2017, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|

|
|